Though these results showed a worsening of disease, the observed immune modulatory effects of PIKfyve inhibitor treatment raised the possibility that a post-exposure treatment regimen could mitigate some of the effects of a cytokine storm, which has been correlated with COVID-19 disease severity1,27. This evidence concerns the gene PIKFYVE and COVID-19.